kidney disease

Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
Business Wire
Otsuka
Tolvaptan
autosomal dominant polycystic kidney disease
kidney disease
Flag link:
Abbott, Reata kidney disease drug trial stopped
Abbott, Reata kidney disease drug trial stopped
Reuters
Abbott
Reata
kidney disease
Bardoxolone
AbbVie
Humira
Flag link:
A Fresh Look At KERX; High Odds For Zerenex Phase III Success
A Fresh Look At KERX; High Odds For Zerenex Phase III Success
Yahoo/Reuters
Keryx
Zerenex
kidney disease
Flag link:
Amgen's Sensipar fails in late-stage trial
Amgen's Sensipar fails in late-stage trial
Pharma Times, UK
Amgen
Sensipar
kidney disease
Flag link:
A Little Confidence Goes a Long Way
A Little Confidence Goes a Long Way
Motley Fool
Keryx
Aeterna Zentaris
Zerenex
renal disease
kidney disease
Torii Pharmaceutical
Flag link:
FDA Turns Down Expanded Use of Mercks’ Vytorin and Zetia
FDA Turns Down Expanded Use of Mercks’ Vytorin and Zetia
Bloomberg
FDA
Vytorin
Merck
Zetia
kidney disease
Flag link:
FDA panel backs expanded use of Merck's Vytorin
FDA panel backs expanded use of Merck's Vytorin
Yahoo/AP
FDA
Merck
Vytorin
kidney disease
Flag link:
Merck’s Vytorin Cuts Heart Risk in Kidney Patients, FDA Says
Merck’s Vytorin Cuts Heart Risk in Kidney Patients, FDA Says
Bloomberg
FDA
Vytorin
Merck
kidney disease
Flag link:
New Data on Abbott Kidney Drug Candidate
New Data on Abbott Kidney Drug Candidate
Yahoo/Zacks.com
Abbott Laboratories
Shire
Sanofi
bardoxolone methyl
Reata
kidney disease
Flag link:
FDA approves kidney disease label for Onglyza
FDA approves kidney disease label for Onglyza
Yahoo/AP
kidney disease
FDA
Onglyza
Flag link:
Let's Call It a Partial Victory (Merck)
Let's Call It a Partial Victory (Merck)
Motley Fool
Merck
Vytorin
kidney disease
Flag link:
Merck Cholesterol Drug Is Found to Help Kidney Patients
Merck Cholesterol Drug Is Found to Help Kidney Patients
WSJ Online
Merck
Vytorin
kidney disease
Flag link:
Abbott Sues Anchen for Infringing U.S. Patent of Its Zemplar Kidney Drug
Abbott Sues Anchen for Infringing U.S. Patent of Its Zemplar Kidney Drug
Bloomberg
Abbott Laboratories
patents
Zemplar
Anchen
kidney disease
Flag link:
FDA may limit anemia drug use for kidney disease
FDA may limit anemia drug use for kidney disease
Yahoo/AP
anemia
kidney disease
FDA
Amgen
Procrit
Aranesp
Epogen
Flag link:
Baxter Creates New Medical Products Business and Announces Key Leadership Changes
Baxter Creates New Medical Products Business and Announces Key Leadership Changes
Baxter International
hemophilia
immune disorders
infectious diseases
kidney disease
trauma
Flag link:
CytoPherx drums up $11.7 million for dialysis development
CytoPherx drums up $11.7 million for dialysis development
CytoPherx
financing
dialysis
kidney disease
Flag link:
Another Genzyme Drug Goes Kaboom
Another Genzyme Drug Goes Kaboom
TheStreet.com
Genzyme
kidney disease
Renvela
APB
Flag link:
Keryx Biopharmaceuticals shares jump as kidney disease drug meets midstage study goal
Keryx Biopharmaceuticals shares jump as kidney disease drug meets midstage study goal
Yahoo/AP
Keryx
drug trials
kidney disease
Zerenex
Flag link:
Impax Laboratories faces lawsuit from Genzyme in patent challenge to kidney drug Renvela
Impax Laboratories faces lawsuit from Genzyme in patent challenge to kidney drug Renvela
Yahoo/AP
Impax
kidney disease
Renvela
Genzyme
patents
Flag link:
Shire sues Natco over generic Fosrenol
Shire sues Natco over generic Fosrenol
Bizjournals.com
Natco
Shire
generics
patents
Forsenol
kidney disease
Flag link:

Pages